SERMS (raloxifene 60mg) vs placebo
Percent change from baseline in leiomyoma size in GHRH‐analogue treated women · patients with uterine leiomyomas
1 finding from 1 review
- Selective estrogen receptor modulators (SERMs) for uterine leiomyomas 2012 · Cochrane Headline outcomes onlyno estimate extracted1 study · 91 participantsLow